Detalhe da pesquisa
1.
Reduction of ZFX levels decreases histone H4 acetylation and increases Pol2 pausing at target promoters.
Nucleic Acids Res
; 2024 May 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-38726870
2.
Adenovirus E1A binding to DCAF10 targets proteasomal degradation of RUVBL1/2 AAA+ ATPases required for quaternary assembly of multiprotein machines, innate immunity, and responses to metabolic stress.
J Virol
; 97(12): e0099323, 2023 Dec 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-37962355
3.
Many People With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Benefit From Ibrutinib Treatment Up To 8 Years: A Plain Language Summary.
Future Oncol
; 2023 01 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36617990
4.
First-line treatment of chronic lymphocytic leukemia with ibrutinib plus obinutuzumab versus chlorambucil plus obinutuzumab: final analysis of the randomized, phase III iLLUMINATE trial.
Haematologica
; 107(9): 2108-2120, 2022 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35021599
5.
Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study.
Lancet
; 395(10241): 1907-1918, 2020 06 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-32473681
6.
Combining Panitumumab With Anti-PD-1 Antibody in Cutaneous Squamous Cell Carcinoma of the Head and Neck After Inadequate Response to Anti-PD-1 Antibody Alone.
J Drugs Dermatol
; 20(8): 901-904, 2021 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34397194
7.
Ibrutinib plus obinutuzumab versus chlorambucil plus obinutuzumab in first-line treatment of chronic lymphocytic leukaemia (iLLUMINATE): a multicentre, randomised, open-label, phase 3 trial.
Lancet Oncol
; 20(1): 43-56, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30522969
8.
Adenovirus E1A Activation Domain Regulates H3 Acetylation Affecting Varied Steps in Transcription at Different Viral Promoters.
J Virol
; 92(18)2018 09 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-29976669
9.
Incontinentia Pigmenti presenting as a newborn eruption: two case presentations.
Dermatol Online J
; 22(6)2016 Jun 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-27617597
10.
Arabidopsis ribosomal proteins control developmental programs through translational regulation of auxin response factors.
Proc Natl Acad Sci U S A
; 109(48): 19537-44, 2012 Nov 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-23144218
11.
Changes in clinical stage identify patients with CLL and different outcome within iwCLL partial response: RESONATE study.
Br J Haematol
; 185(1): 148-150, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29855051
12.
A long-term fulvestrant eluting implant is safe, non-toxic, and reduces the risk of breast cancer in in vivo models.
Res Sq
; 2023 Oct 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-37961240
13.
Characteristics and Clinical Outcomes of Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Receiving Ibrutinib for ≥5 Years in the RESONATE-2 Study.
Cancers (Basel)
; 15(2)2023 Jan 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-36672456
14.
Interplay of Immunosuppression and Immunotherapy Among Patients With Cancer and COVID-19.
JAMA Oncol
; 9(1): 128-134, 2023 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36326731
15.
Expression patterns and function of chromatin protein HMGB2 during mesenchymal stem cell differentiation.
J Biol Chem
; 286(48): 41489-41498, 2011 Dec 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-21890638
16.
Defining the Current Landscape, Attitudes, and Perceived Barriers of Virtual Medicine in Underserved Populations.
JCO Oncol Pract
; 18(12): e1987-e1995, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36256906
17.
Disseminated Mycobacterium abscessus Infection in a Burn Patient.
J Burn Care Res
; 43(3): 742-745, 2022 05 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-35104355
18.
Up to 6.5 years (median 4 years) of follow-up of first-line ibrutinib in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma and high-risk genomic features: integrated analysis of two phase 3 studies.
Leuk Lymphoma
; 63(6): 1375-1386, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35014928
19.
Up to 8-year follow-up from RESONATE-2: first-line ibrutinib treatment for patients with chronic lymphocytic leukemia.
Blood Adv
; 6(11): 3440-3450, 2022 06 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-35377947
20.
Promoter-specific changes in initiation, elongation, and homeostasis of histone H3 acetylation during CBP/p300 inhibition.
Elife
; 102021 03 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-33704060